Key Takeaways
- Sector: Healthcare, Healthtech & Medtech, Financial Services & Fintech.
- Geography: United Kingdom.
Analysis
Grant Goodwin, an Investment Director at LDC, has earned a distinguished spot as a finalist in the prestigious HealthInvestor Power List 2026. This annual recognition celebrates influential figures shaping the health and social care sectors, highlighting their strategic acumen and impact on the industry.
Goodwin's inclusion in the Equity Investor category underscores his significant contributions to impactful businesses through astute investment strategies and a focus on maximizing returns. The HealthInvestor Power List is a benchmark for leadership within the healthcare investment community, drawing attention to individuals who drive substantial growth and innovation.
His recent activity showcases a dynamic approach to portfolio management and strategic expansion. Notably, Goodwin was instrumental in LDC's December 2025 investment in myHappymind, a move that aligns with the growing demand for mental wellness solutions. Furthermore, he facilitated Panthera Biopartners' strategic acquisition of the Hungary-based entity OEC in April 2026, broadening the company's European footprint. This dual focus on new investments and strategic acquisitions reflects a robust understanding of market opportunities.
Adding to his notable achievements, Goodwin played a pivotal role in the successful divestment of PAM Healthcare to Optima Health PLC in March 2026 for a substantial £100 million. This exit exemplifies LDC's capability in identifying high-potential businesses and realizing significant value for stakeholders. Beyond these specific transactions, Goodwin continues to provide critical support to LDC's existing healthcare portfolio, which comprises 14 diverse businesses, actively collaborating with management teams to achieve their growth objectives.
LDC itself boasts a long-standing commitment to the healthcare sector, with decades of experience supporting management teams across healthcare services, pharmaceutical services, and MedTech & devices. Over the past decade, the firm has deployed £448 million into 19 rapidly expanding healthcare companies, which collectively represented an enterprise value of £902 million at the time of investment. This deep sector expertise positions LDC as a key player in driving forward healthcare innovation and consolidation.
The culmination of the HealthInvestor Power List 2026 will be marked by an awards ceremony at the London Marriott on December 3, 2026, where the winners across all categories, including Equity Investor, will be announced. Goodwin's recognition highlights the critical role of private equity in fostering advancements and delivering value within the vital health and social care industries.